Drug delivery strategies to treat age-related macular degeneration

Advanced Drug Delivery Reviews

Volumn 57, Issue 14 SPEC. ISS., 2005, Pages 1991-1993

  Olejnik, Orest ^a   Hughes, Patrick ^a  

^a ALLERGAN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANECORTAVE; BENZOPORPHYRIN DERIVATIVE; DEXAMETHASONE; ENDOTHELIAL CELL GROWTH FACTOR; PEGAPTANIB; RANIBIZUMAB; SMALL INTERFERING RNA; SQUALAMINE; TRIAMCINOLONE ACETONIDE; VASCULOTROPIN;

BLINDNESS; CHOROID; DRUG DELIVERY SYSTEM; EDITORIAL; HUMAN; LASER COAGULATION; PATHOPHYSIOLOGY; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 28444461800     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2005.09.002     Document Type: Editorial

References (2)

1. J.A. Tielsch Vision problems in the US: a report on blindness and vision impairment in adults age 40 and older Prevent Blindness America. Schaumburg, Ill: Prevent Blindness 1994
2. Y. Ogura Drug delivery to the posterior segments of the eye Adv. Drug Deliv. Rev. 52 2001 1 3